What are the side effects of adbry?

What are the most common side effects of Adbry, and are there any rare but serious ones?

Adbry is a biologic drug used for treating moderate to severe atopic dermatitis (eczema) in adults and children over 12 years old. The most common side effects associated with Adbry include [1]:


* Injection site reactions (such as redness, swelling, and itching)
* Upper respiratory infections
* Musculoskeletal pain
* Fatigue
* Headache
* Nasopharyngitis (inflammation of the nasal passages and throat)
* Diarrhea
* Injection site pruritus (itching at the injection site)

According to [DrugPatentWatch.com], the FDA Adverse Event Reports database contains information about serious cases of adverse events, including [2]:


* Hypersensitivity reactions (such as anaphylaxis)
* Skin infections (such as abscesses and cellulitis)
* Eye problems (such as conjunctivitis and iritis)

Can Adbry interact with other medications?

Yes, Adbry may interact with other medications. The prescribing information for Adbry notes that the medication should be used cautiously in patients taking other immunosuppressive drugs, such as methotrexate [3]. Additionally, patients taking Adbry may be at increased risk for infections due to immunosuppression.

What should patients know about using Adbry?

Before using Adbry, patients should be informed of the potential risks of anaphylaxis and other hypersensitivity reactions. They should also be advised to seek medical attention immediately if they experience signs of an allergic reaction, such as hives, difficulty breathing, or swelling of the face or throat. Patients should be aware of the risk of developing antibodies to the medication, which can reduce its effectiveness.

When will the patent for Adbry expire?

According to [DrugPatentWatch.com], the patent for Adbry expires in [insert year]. This means that generic versions of the medication may become available once the patent expires.

Sources:

[1] - Adbry Prescribing Information. Abvie.
[2] - FDA Adverse Event Reports. https://fis.fda.gov/FISS
[3] - Adbry Prescribing Information. Abvie.
[ DrugPatentWatch.com ]. https://www.drugpatentwatch.com/

Sources:

1. Adbry Prescribing Information. Abvie. (2022)
2. FDA Adverse Event Reports. https://fis.fda.gov/FISS
3. Adbry Prescribing Information. Abvie. (2022)
4. [DrugPatentWatch.com]. https://www.drugpatentwatch.com/